US Patent Issued to Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical on June 10 for "Anti-ABeta antibodies and antigen-binding fragments thereof" (Chinese Inventors)

ALEXANDRIA, Va., June 18 -- United States Patent no. 12,325,741, issued on June 10, was assigned to Jiangsu Hengrui Medicine Co. Ltd. (Lianyungang, China) and Shanghai Hengrui Pharmaceutical Co. Ltd. (Shanghai).

"Anti-ABeta antibodies and antigen-binding fragments thereof" was invented by Hua Ying (Shanghai), Ling Zhang (Shanghai), Jinping Shi (Shanghai), Xiaomin Zhang (Shanghai), Jiakang Sun (Shanghai), Qiyue Hu (Shanghai) and Weikang Tao (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Murine, chimeric or humanized anti-Abeta antibody having a specific CDR region, an antigen-binding fragment thereof, a pharmaceutical composition thereof, and usage thereof. Use of a humanized anti-Abeta antibody for...